![]() |
Volumn 17, Issue 4, 2012, Pages 426-428
|
Economic and quality of life evaluation of different modalities of immunoglobulin therapy in chronic dysimmune neuropathies
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IMMUNOGLOBULIN;
BODY WEIGHT;
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY;
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
COST MINIMIZATION ANALYSIS;
DRUG COST;
DRUG DOSE REGIMEN;
DRUG SAFETY;
DRUG TOLERABILITY;
EVIDENCE BASED MEDICINE;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOTHERAPY;
INFUSION PUMP;
LETTER;
MOTOR NEUROPATHY;
OUTCOME ASSESSMENT;
PATIENT MONITORING;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SENSITIVITY ANALYSIS;
SHORT FORM 36;
SOCIAL STATUS;
AUTOIMMUNE DISEASES;
CHRONIC DISEASE;
COST CONTROL;
COST-BENEFIT ANALYSIS;
COSTS AND COST ANALYSIS;
HOME CARE SERVICES;
HUMANS;
IMMUNIZATION, PASSIVE;
IMMUNOGLOBULINS, INTRAVENOUS;
INJECTIONS, SUBCUTANEOUS;
PERIPHERAL NERVOUS SYSTEM DISEASES;
POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;
QUALITY OF LIFE;
QUESTIONNAIRES;
|
EID: 84872833575
PISSN: 10859489
EISSN: 15298027
Source Type: Journal
DOI: 10.1111/j.1529-8027.2012.00444.x Document Type: Letter |
Times cited : (18)
|
References (3)
|